Stryker Corporation (SYK)

Market Cap	151.06B
Revenue (ttm)	23.22B
Net Income (ttm)	2.86B
Shares Out	382.16M
EPS (ttm)	7.40
PE Ratio	53.42
Forward PE	29.07
Dividend	$3.36 (0.85%)
Ex-Dividend Date	Jun 30, 2025

Volume	536,296
Open	393.63
Previous Close	391.81
Day's Range	390.31 - 395.50
52-Week Range	314.93 - 406.19
Beta	0.92
Analysts	Buy
Price Target	424.56 (+7.41%)
Earnings Date	Jul 31, 2025

About SYK

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 53,000
• Stock Exchange: NYSE
• Ticker Symbol: SYK
• Website: https://www.stryker.com

Financial Performance

In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.

Analyst Summary

According to 19 analysts, the average rating for SYK stock is "Buy." The 12-month stock price target is $424.56, which is an increase of 7.41% from the latest price.

Price Target

$424.56

(7.41% upside)

Analyst Consensus: Buy